POSTER SESSION INDEX

JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/01.qai.0000413724.94235.a8
Poster Session Index

    A1—A Retrospective Study of Presenting Clinical and Laboratory Variables in HIV Negative Tuberculous Meningitis Patients

    Brian Chisulo - Nanfang Hospital

    A2—Molecular Evolution of Hepatitis C Virus (HCV) and Clinical Outcome in Patients with Hepatitis C

    Patrizia Farci - LID

    A3—Efficacy and Adverse Effects of Commonly Prescribed First-Line HAART Regimens in China

    Siame Gilbert - Department of Epidemiology and Biostatistics, Jilin University, School of Public Health, Changchun, Jilin, China and Zambia Rural Healthcare Outreach Services

    A4—HIV Suicide for Microbicide

    Karin Moelling - Institute of Med Microbiology, Max Planck Institute for Molecular Genetics

    A5—CCR5 Antibodies HGS004 and HGS101 Preferentially Inhibit Drug-Bound CCR5 Infection and Restore Drug Sensitivity of Maraviroc - Resistant HIV-1 in Primary Cells

    Olga Latinovic - Institute of Human Virology

    A6—Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of Chronically Infected,Treatment-Naïve HIV-1 Patients

    Clara Lehmann - Institute of Human Virology, Baltimore, MD; University of Cologne

    A7—Possible Transmission of HIV Infection Due to Human Bite

    Shivaji K Jadhav - National Institute for Research in Reproductive Health, Parel, Mumbai,INDIA

    A8—Immediate Versus Delayed Initiation of Oral Antiretroviral Therapy (ART) Significantly Reduces HIV Transmission: A Survey of Implications of the HPTN 052 Study Results on the Sexual and ART-Seeking Attitudes and Behaviors of Sexually Active HIV Positive and HIV Negative Adults in Zambia

    Ndopu Sthembile - Zambia Rural Healthcare Outreach Services

    A9—A Survey of the Prevalence of HIV and Syphilis Infections and Sexual Behaviors Among MSM in Jilin Province, China

    Yao Yan - Department of Epidemiology and Biostatistics, Jilin University, School of Public Health

    A10—The Potential Role of Antibodies to the C5 Domain of gp120 in Mitigating Generalized Immune Activation Associated With HIV-1 Infection

    A. Dalgleish - St. Georges, University of London, Division of Oncology, Department of CMM, London, United Kingdom

    B1—Virus Like Particle Based Strategy to Elicit Antibodies to an HIV-Protective Epitope Within the Alpha-Helic Region of gp41

    V. Asti - Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute

    B2—Enhancing Cellular Immune Responses to SIV Gag DNA Vaccine by Suppressing Fas-FasL Signaling

    Jiabin Yan

    B3—Identification of Neutralizing Antibodies and Their Epitopes from HIV Controllers

    Ursula Dietrich - Georg-Speyer-Haus

    B4—Immunotherapy of HIV-1-Infected Patients with Dendritic Cells Transfected with gag and tat-rev-nef mRNA

    Z. N. Berneman - Center for Cell Therapy and Regenerative Medicine (CCRG) and Antwerp University Hospital

    B5—Productive HIV-1 Infection of Cervical Tissue Ex Vivo

    Elisa Saba - AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute, Milano, Italy; and Vita-Salute San Raffaele University, School of Medicine, Milano, Italy

    C1—Evaluation of Novel HIV Envelopes in Rabbits Immunized with a DNA Prime/Protein Boost Vaccine Regimen

    A. D. Cristillo - Advanced BioScience Laboratories Inc

    C2—The Dependence of HIV Control Upon MHC Helical Conformational Dynamics

    Kurt H. Piepenbrink - The Institute of Human Virology

    C3—HIV-1 Env and HLA-C: Friends or Foes?

    Donato Zipeto - University of Verona

    C4—Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation

    Donato Zipeto - University of Verona

    D1—Small RNA and HIV Infection - An Important Role in Control of Latency

    Zvi Bentwich - Ben Gurion University Faculty of Health Sciences

    D2—HIV-1 p17 Activates PTEN and Inhibits Akt Signalling Pathway in B Cells: Evidence for a p17 Variant with Opposite Effects

    Francesca Caccuri - Institute of Microbiology, University of Brescia Medical School

    D3—HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin (LtxA)

    C. E. Hioe - NYU and VA Medical Centers

    D4—Expression of Human Endogenous Retrovirus Type-K (HML-2) is Activated by the Tat Protein of HIV-1

    Marta J. Gonzalez-Hernandez - University of Michigan

    D5—Impaired Gamma Delta T Cell Proliferation in the Presence of Certain Viral Envelopes Can Be Overcome by Addition of DC

    Kanta Dutta - Institute of Human Virology, Univ of MD School of Medicine

    D6—Estimation and Projection of HIV Epidemic Among High-Risk Populations in Jilin Province, China

    Li Bo - Department of Expidemiology and Biostatistics, School of Public Health

    D7—Correlation Between CD4 T Cell Counts and Virus Compartmentalization in Genital and Systemic Compartments of HIV-Infected Females

    Suman Chaudhary - AIDS Research Program, Ponce School of Medicine

    E1—Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication

    Chiara Orlandi - Institute of Human Virology, University of Maryland

    E2—The MHC-II Transactivator CIITA, a Viral Restriction Factor Targeting Human T-Cell Lymphotropic Virus Type 1 Tax-1 Function and Inhibiting Viral Replication

    Giovanna Tosi and Roberto S. Accolla - Department of Experimental Medicine, University of Insubria

    E3—Inhibition of HIV Infection in Highly Susceptible Cells with Human β-Defensins – Induction of APOBEC3G Via Chemokine Receptors

    Alfredo Garzino-Demo - Institute of Human Virology and Department of Microbiology and Immunology

    E4—Modeling HIV-1 Latency in vitro

    Maria Iglesias-Ussel - Institute of Human Virology, University of Maryland School of Medicine

    E5—A Convenient Mouse Model for Acute HIV Infection Mimicking Pathogenesis in Humans

    Senthilkumar Natesan - Institute of Human Virology; University of Maryland School of Medicine

    E6—Immune Response and Selective Depletion of CD4-Negative T Cell: Impact of Chronic HIV Exposure on the TCR-γ2 Chain Repertoire

    Suchita Chaudhry - Institute of Human Virology

    F1—Cancer Stem Cell Features in Subpopulations Isolated from Kaposi's Sarcoma Cell Cultures

    A. Albini - Oncology Research, Casa di Cura MultiMedica-IRCCS

    F2—Quality Assurance of Nurse Provider Led Cervical Cancer Screening in Nigeria

    Clement Adebamowo - Office of Strategic Information, Research and Training, Institute of Human Virology, Abuja and Department of Epidemiology, Institute of Human Virology, University of Maryland School of Medicine

    F3—Knowledge Attitude and Practice of Malignancies Among PLWHIV in Nigeria

    Clement Adebamowo - Office of Strategic Information, Research and Training, Institute of Human Virology, Abuja and Department of Epidemiology, Institute of Human Virology, University of Maryland School of Medicine

    F4—Characteristics and Outcomes of HIV-infected Patients Diagnosed with Cancer in an Urban Setting

    David J. Riedel - Institute of Human Virology, University of Maryland School of Medicine

    F5—The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve HLA Class I Antigen Recognition Groove

    Stephen J. O'Brien - Laboratory of Genomic Diversity, National Cancer Institute

    F6—γδ T Cells in HIV-Infected Individuals With Persistent Viremia

    Sarah Boudová - Institute for Human Virology

    © 2012 Lippincott Williams & Wilkins, Inc.